Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- New GCP GL Fully Applied in Most Clinical Trials At Present
July 1, 2002
- DTC Advertisements in Japan Discussed: JPMA Seminar
July 1, 2002
- Report on New Drug Evaluation System Compiled by Study Group
July 1, 2002
- BUSINESS NEWS IN BRIEF
July 1, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
July 1, 2002
- WEBSITE NEWS
July 1, 2002
- DIAGNOSTIC NEWS IN BRIEF
July 1, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
July 1, 2002
- Meeting the Entry of Wal-Mart: JACDS Seminar
July 1, 2002
- Korosho to Finalize Drug Industry Vision by Summer
July 1, 2002
- Functional Food Foundation Set Up
July 1, 2002
- Less than Half of Companies Have PAL Compliance System
July 1, 2002
- OTC NEWS IN BRIEF
July 1, 2002
- Clinical Efficacy Is More Important in Selecting Comparator Drugs: Dr Yazaki of DPO
July 1, 2002
- WORLD NEWS IN BRIEF
July 1, 2002
- FPMAJ Proposes Concrete Application Rule for New NHI Pricing Method
July 1, 2002
- Pharmacia to Double Sales, Enter Top 10 in 2005: Mr Yamaki
July 1, 2002
- 75% of the Elderly Enjoy Healthy Life: White Paper
July 1, 2002
- Basic Policy for FY2003 Budget Formation Recommended by Council
July 1, 2002
- Expert Panel Presents Interim Report on IP
July 1, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…